Braendstrup, P., Mortensen, B.K., Justesen, S., Osterby, T., Rasmussen, M., Hansen, A.M., Christiansen, C.B., Hansen, M.B., Nielsen, M., Vindeløv, L., Buus, S. and Stryhn, A. (2014). Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2. PloS One, [online] 9(4), p.e94892. Available at: https://pubmed.ncbi.nlm.nih.gov/24760079 [Accessed 26 May 2021].
Crosby, E.J., Gwin, W., Blackwell, K., Marcom, P.K., Chang, S., Maecker, H.T., Broadwater, G., Hyslop, T., Kim, S., Rogatko, A., Lubkov, V., Snyder, J.C., Osada, T., Hobeika, A.C., Morse, M.A., Lyerly, H.K. and Hartman, Z.C. (2019). Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, [online] 25(9), pp.2725–2736. Available at: https://pubmed.ncbi.nlm.nih.gov/30635338.
de Wit, J., Emmelot, M.E., Poelen, M.C.M., Lanfermeijer, J., Han, W.G.H., van Els, C.A.C.M. and Kaaijk, P. (2019). The Human CD4+ T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope. Journal of Virology, [online] 93(6). Available at: https://jvi.asm.org/content/93/6/e01883-18 [Accessed 1 Nov. 2019].
Holmes, T.H., Subrahmanyam, P.B., Wang, W. and Maecker, H.T. (2019). Penalized Supervised Star Plots: Example Application in Influenza-Specific CD4+ T Cells. Viral Immunology, 32(2), pp.102–109.
Luah, Y.H., Sundar Raj, K., Koh, M.B.C. and Linn, Y.C. (2019). A novel simplified method of generating cytomegalovirus-specific cytokine-induced killer cells of high specificity and superior potency with GMP compliance. Clinical Immunology, 205, pp.83–92.
Przybyla, A., Zhang, T., Li, R., Roen, D.R., Mackiewicz, A. and Lehmann, P.V. (2019). Natural T cell autoreactivity to melanoma antigens: clonally expanded melanoma-antigen specific CD8 + memory T cells can be detected in healthy humans. Cancer immunology, immunotherapy: CII, [online] 68(5), pp.709–720. Available at: https://pubmed.ncbi.nlm.nih.gov/30783693/ [Accessed 26 May 2021].
Ragonnaud, E., Schroedel, S., Mariya, S., Iskandriati, D., Pamungkas, J., Fougeroux, C., Daradoumis, J., Thomsen, A.R., Neukirch, L., Ruzsics, Z., Salomon, M., Thirion, C. and Holst, P.J. (2018). Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques. Vaccine, [online] 36(41), pp.6212–6222. Available at: https://pubmed.ncbi.nlm.nih.gov/30190120 [Accessed 26 May 2021].
van de Loosdrecht, A.A., van Wetering, S., Santegoets, S.J.A.M., Singh, S.K., Eeltink, C.M., den Hartog, Y., Koppes, M., Kaspers, J., Ossenkoppele, G.J., Kruisbeek, A.M. and de Gruijl, T.D. (2018). A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia. Cancer immunology, immunotherapy: CII, [online] 67(10), pp.1505–1518. Available at: https://pubmed.ncbi.nlm.nih.gov/30039426 [Accessed 26 May 2021].
Withers, B., Clancy, L., Burgess, J., Simms, R., Brown, R., Micklethwaite, K., Blyth, E. and Gottlieb, D. (2018). Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, [online] 24(12), pp.2433–2442. Available at: https://pubmed.ncbi.nlm.nih.gov/30172015 [Accessed 26 May 2021].